These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37773787)
1. Lennox-Gastaut syndrome characterized by super-refractory status epilepticus treated with high-dose anesthetics: A case report. Yang X; Xu G; Chong Z; Liang Y; Du J; Zhao L; Chen W Medicine (Baltimore); 2023 Sep; 102(39):e35233. PubMed ID: 37773787 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US. Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546 [TBL] [Abstract][Full Text] [Related]
3. Refractory generalised convulsive status epilepticus : a guide to treatment. Kälviäinen R; Eriksson K; Parviainen I CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991 [TBL] [Abstract][Full Text] [Related]
4. Propofol-induced refractory status epilepticus at remission age in benign epilepsy with centrotemporal spikes: A case report and literature review. Lu L; Xiong W; Zhang Y; Xiao Y; Zhou D Medicine (Baltimore); 2019 Jul; 98(27):e16257. PubMed ID: 31277145 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant-induced status epilepticus in Lennox-Gastaut syndrome. Bittencourt PR; Richens A Epilepsia; 1981 Feb; 22(1):129-34. PubMed ID: 6781886 [TBL] [Abstract][Full Text] [Related]
9. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT. Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679 [TBL] [Abstract][Full Text] [Related]
10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
11. LMR-101, a novel derivative of propofol, exhibits potent anticonvulsant effects and possibly interacts with a novel target on γ-aminobutyric acid type A receptors. Zhao Y; An L; Guo S; Huang X; Tian H; Liu L; Chen T; Sun X; Mei Q; Wang R Epilepsia; 2021 Jan; 62(1):238-249. PubMed ID: 33417274 [TBL] [Abstract][Full Text] [Related]
12. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus. Kravljanac R; Djuric M; Jankovic B; Pekmezovic T Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults. Holtkamp M Drugs; 2018 Mar; 78(3):307-326. PubMed ID: 29368126 [TBL] [Abstract][Full Text] [Related]
14. Status epilepticus: Refractory and super-refractory. Dubey D; Kalita J; Misra UK Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491 [TBL] [Abstract][Full Text] [Related]
15. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy. Villanueva V; García-Ron A; Smeyers P; Arias E; Soto V; García-Peñas JJ; González-Alguacil E; Sayas D; Serrano-Castro P; Garces M; Hampel K; Tomás M; Lara J; de Toledo M; Barceló I; Aledo-Serrano A; Gil-Nagel A; Iacampo L; Falip M; Saiz-Diaz RA; Gómez-Ibañez A; Sopelana D; Sanchez-Larsen A; López-González FJ Epilepsy Behav; 2022 Dec; 137(Pt A):108958. PubMed ID: 36327646 [TBL] [Abstract][Full Text] [Related]
16. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K; Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273 [TBL] [Abstract][Full Text] [Related]